The first session “Complexities in Evaluating Human Clinical and Observational Data for Ingredient Safety Assessment: Partially Hydrogenated Oils (PHOs) As a Case Study” will be November 7, 2014. This event also accessible by webcast.
Training programs pertaining to teratology, developmental toxicology, or reproductive toxicology.
In this issue of BDRC are reviews that lay out a wealth of history about the remarkable neural crest cells with controversies addressed and therapeutic promise revealed.
NIH will accept responses through October 13, 2014. FASEB is working with the Animals in Research and Education Subcommittee and the Clinical and Translational Research Subcommittee to develop a letter to be sent to NIH on balancing sex in research.
This special issue is dedicated to the presentations of the 8th International Conference on Neural Tube Defects held October 7-10, 2013 in Austin, Texas.